` NNNN (Anbio Biotechnology) vs S&P 500 Comparison - Alpha Spread

A
NNNN
vs
S&P 500

Over the past 12 months, NNNN has significantly outperformed S&P 500, delivering a return of +481% compared to the S&P 500's +14% growth.

Stocks Performance
NNNN vs S&P 500

Loading
NNNN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NNNN vs S&P 500

Loading
NNNN
S&P 500
Difference
www.alphaspread.com

Performance By Year
NNNN vs S&P 500

Loading
NNNN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Anbio Biotechnology vs Peers

S&P 500
NNNN
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Anbio Biotechnology
Glance View

Market Cap
4.8B USD
Industry
Biotechnology

Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.

NNNN Intrinsic Value
Not Available
A
Back to Top